Monoclonal Antibodies

The signaling pathways controlling cell growth and differentiation are almost invariably altered in cancer, and deciphering these interconnected signaling pathways is leading to the development of monoclonal antibody cancer drugs. To design a monoclonal antibody, researchers first have to identify the right target antigen to attack…

Cancer Vaccines

Monitoring autoantibody levels and the response to antigens will help us further understand anti-tumor immunity and may also help us to monitor cancer progress and cancer vaccine efficacy in the future….

LC Sciences offers a range of services applicable to clinical cancer research . Contact us to find out more.


VariantPro™ Targeted Sequencing

The VariantPro system is an innovative multiplex PCR based targeted sequencing method that accomplishes target selection, library preparation and molecular tagging in a simple one-step workflow. [learn more…]

Exome Sequencing

Exome sequencing is an efficient strategy to selectively sequence the coding regions of the genome as a less expensive but still effective alternative to whole genome sequencing. [learn more…]


Cancer Antigen Arrays

The additional knowledge gained by studying the response to antigens at the epitope level will help us further understand anti-tumor immunity and may also help us to monitor cancer progress and cancer vaccine efficacy in the future. [learn more…]

Protein Profiling Arrays

Systems Biology has emerged as an effective approach to studying complex interactions within biological systems. By studying entire networks or pathways, we can better understand the underlying structure of cell signaling networks. [learn more…]


microRNA Profiling

microRNAs are small noncoding RNA molecules that function broadly as negative regulators of gene expression to control a wide range of cellular processes. [learn more…]

RNA Sequencing

Our comprehensive sequencing services make use of the latest in next-gen sequencing technologies. Illumina’s industry-leading RNA sequencing methods enable discovery [learn more…]